Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
As of: Aug 19, 2026 · 3:35 PM EDT

Vireo Growth (VREOF) Revenue Growth (5y) (2025 - 2026)

Vireo Growth (VREOF) Revenue Growth (5y) (2025 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Haleon 43.87 Bn 42.91 Bn -
2 Teva Pharmaceutical Industries 43.21 Bn 39.55 Bn 2.15 Bn
3 Zoetis 31.48 Bn 29.80 Bn 1.05 Bn
4 Takeda Pharmaceutical 28.60 Bn 22.80 Bn 5.10 Bn
5 United Therapeutics 22.19 Bn 19.53 Bn 683.80 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn
7 Neurocrine Biosciences 15.49 Bn 15.10 Bn 935.80 Mn
8 Elanco Animal Health 11.70 Bn 11.17 Bn 798.00 Mn
9 Dr Reddys Laboratories 10.13 Bn 9.97 Bn -
10 Vireo Growth 489.19 Mn 346.89 Mn 95.30 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 51.77%
Dec 31, 2025 53.16%
Sep 30, 2025 49.01%
Jun 30, 2025 31.52%
Mar 31, 2025 15.12%